오션스바이오 Stock: price and insider trades · South Korea
No insider purchase over the last 90 days. The latest, by 캡스톤파트너스, was filed 01 Apr 2026.
오션스바이오: what insiders have been doing
오션스바이오, classified in the Health Care sector, is a listed company. Its insiders report their share dealings to DART (FSS). 1 insider has disclosed 2 filings since 2 November 2025.
Every open-market trade in the period is a purchase: 2 purchases, from 1 insider, and not a single sale. The amount is not disclosed for 2 filings. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
Compared with its exchange (2,655 companies, median 7 filings), a count of 2 filings is below the norm. Our records for 오션스바이오 go back to 2025, with 2 purchases and 1 sale on the open market in total.
The last purchase on record was published on 1 April 2026, which is 223 days ago.
Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and UCB. This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.
Who traded when
BuySaleFinancial data
· cache
About 오션스바이오
Oceans Bio is in the health and pharmaceutical sector, listed on the XKRX market. The company focuses on developing innovative biological solutions.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
